Article

Vistakon to discontinue Acuvue Toric brand

Jacksonville, FL?The Vistakon division of Johnson & Johnson Vision Care Inc. will discontinue its Acuvue Toric contact lenses as of January.

End in sight

Jacksonville, FL-The Vistakon division of Johnson & Johnson Vision Care Inc. will discontinue its Acuvue Toric contact lenses as of January.

The decision was made, according to Vistakon, because the company's Acuvue Advance for Astigmatism lenses have generated strong sales resulting from design features that make them "a better option for current Acuvue Toric patients," said Pat Cummings, OD, vice president-professional affairs and customer development.

To help patients who have been wearing Acuvue Toric lenses make a smooth transition, Vistakon will offer a $75 rebate following an eye exam and purchase of a 1-year supply of Acuvue Advance for Astigmatism lenses.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.